Trial Profile
A Single-Center, Single-Dose, Randomized, Open-Label, Four-Period, Four-Treatment Crossover Study Evaluating Pharmacokinetic Properties Of Low-Dose SoluMatrix Meloxicam In Healthy Adults.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Mar 2017
Price :
$35
*
At a glance
- Drugs Meloxicam (Primary) ; Meloxicam
- Indications Musculoskeletal pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Iroko Pharmaceuticals
- 25 Nov 2014 New trial record